April 2025: Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis

American Journal of Psychiatry Audio by American Psychiatric Association Publishing

Apr 1, 202523:11Religion & Spirituality

Dr. Valentina Mancini (Oxford University) joins AJP Audio to discuss the impact of anticholinergic burden on cognition in patients with schizophrenia. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin puts the rest of the Ma...

Related Episodes

Continue listening to more episodes from American Journal of Psychiatry Audio.

May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample

May 1, 2026 - 30:15

Dr. Eduardo Butelman (Icahn School of Medicine at Mount Sinai, New York) joins AJP Audio to discuss the v...

April 2026: Mobile Health for Alcohol Use Assessment: Longitudinal Effects of Breathalyzer Self-Monitoring in Everyday Contexts

Apr 1, 2026 - 35:58

Yang Lu, M.S., and Catharine E. Fairbairn, Ph.D. (University of Illinois, Urbana- Champaign) join AJP Aud...

March 2026: Primary Prevention of PTSD Symptoms in Combat-Deploying Soldiers Using Attention Bias Modification: A Randomized Controlled Trial

Mar 1, 2026 - 33:17

Chelsea Dyan Gober Dykan, M.A. (Tel Aviv University, Israel), joins AJP Audio to discuss a study looking...

February 2026: Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial

Feb 1, 2026 - 29:58

Dr. Ian Kelleher (University of Edinburgh, Scotland) joins AJP Audio to discuss an emulated target trial...

Special Episode: 2025 Articles of Import and Impact

Jan 23, 2026 - 33:12

This special episode of AJP Audio brings together the editors of the American Journal Psychiatry and the...

January 2026: Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders

Jan 1, 2026 - 26:13

Dr. Julia Linke (University of Mainz, Germany) joins AJP Audio to discuss the use of neural efficiency ,...

December 2025: Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial

Dec 1, 2025 - 22:12

Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio...

November 2025: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study

Nov 1, 2025 - 27:14

Dr. Lara Coughlin (University of Michigan, Ann Arbor) joins AJP Audio to discuss a study looking the impa...